SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Assessment of transparency of cost estimates in economic evaluations of patient safety programmes
16 references·0 citing·26 second hop
Assessment of transparency of cost estimates in economic evaluations of patient safety programmes (2009)Assessment of transparency of cost estima…Systematic review of economic analyses of health care-associated infections (2005)Systematic review of economic…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Cost-of-illness analysis (2005)Cost-of-illness analysisMEASURING COSTS IN COST-UTILITY ANALYSES (2000)MEASURING COSTS IN COST-UTILI…Economic Note: Cost of illness studies (2000)Economic Note: Cost of illnes…The Role of Cost-effectiveness Analysis in Health and Medicine (1996)The Role of Cost-effectivenes…The ratio of costs to charges: how good a basis for estimating costs? (1996)The ratio of costs to charges…Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations of the Panel …Recommendations for Reporting Cost-effectiveness Analyses (1996)Recommendations for Reporting…Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Guidelines for authors and pe…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Cost-of-illness studies: fact or fiction? (1994)Cost-of-illness studies: fact…Issues in the Cross-National Assessment of Health Technology (1992)Issues in the Cross-National …Cost-of-Illness Studies (1992)Cost-of-Illness StudiesCost of illness studies: An aid to decision-making? (1987)Cost of illness studies: An a…The Distinction Between Cost and Charges (1982)The Distinction Between Cost …Methods for the economic evaluation of health care programmes (1987)Quality of life and pharmacoeconomics in clinical trials (1996)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)EuroQol - a new facility for the measurement of health-related quality of life (1990)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)Criteria for evaluating evidence on public health interventions (2002)Estimating the cost of illness. (1967)A Practical Guide for Calculating Indirect Costs of Disease (1996)Cost-of-illness studies of depression (2006)The Economic Burden of Personality Disorders in Mental Health Care (2008)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)The estimation of a preference-based measure of health from the SF-36 (2002)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)Clinical Economics (1989)A Clinician's Guide to Cost-Effectiveness Analysis (1990)Cost of Care for Elderly Cancer Patients in the United States (2008)The Application of Root Cause Analysis and Target Value Design to Evidence-Based Design in the Capital Planning of Healthcare Facilities (2009)REDENOMINASI, NILAI MATA UANG DAN EKSISTENSI EMAS DI ERA COVID-19 (2020)A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial (2012)Cost of stroke in the United Kingdom (2008)Cost-of-Illness Studies (2011)The cost of mental disorders: a systematic review (2020)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 1996Recommendations of the Panel on Cost-Effectiveness in Health and Medicine2,507 cited
  • 1996Guidelines for authors and peer reviewers of economic submissions to the BMJ1,828 cited
  • 1996The Role of Cost-effectiveness Analysis in Health and Medicine1,277 cited
  • 1996Recommendations for Reporting Cost-effectiveness Analyses1,274 cited
  • 1982The Distinction Between Cost and Charges1,055 cited
  • 2005Cost-of-illness analysis545 cited
  • 1992Cost-of-Illness Studies489 cited
  • 2005Systematic review of economic analyses of health care-associated infections338 cited
  • 2000Economic Note: Cost of illness studies318 cited
  • 1994Cost-of-illness studies: fact or fiction?213 cited
  • 1996The ratio of costs to charges: how good a basis for estimating costs?205 cited
  • 1987Cost of illness studies: An aid to decision-making?178 cited
  • 1992Issues in the Cross-National Assessment of Health Technology160 cited
  • 2000MEASURING COSTS IN COST-UTILITY ANALYSES

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

126 cited

Cited by

No citing works inside the corpus for this window.